Augmented Reality Rehabilitation for Stroke-Related Neglect
Trial Summary
What is the purpose of this trial?
The aim of this phase is to examine the feasibility and acceptability of the Augmented Reality (AR)-based and electroencephalography (EEG)-based neglect detection and rehabilitation tool.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Augmented Reality Rehabilitation for Stroke-Related Neglect?
Research shows that using augmented reality (AR) and electroencephalography (EEG) can help detect and predict visual neglect in stroke patients, suggesting that AR-based treatments like the AREEN System and NAMI App may be effective. Additionally, studies on similar AR and virtual reality therapies have shown improvements in attention and orientation in stroke patients with spatial neglect.12345
Is augmented reality rehabilitation safe for humans?
How does augmented reality rehabilitation differ from other treatments for stroke-related neglect?
Augmented reality rehabilitation for stroke-related neglect is unique because it uses technology to create an interactive environment that helps patients actively explore and improve their attention and orientation. This approach is different from traditional therapies as it combines visual and motion tracking technologies to engage patients in a more immersive and engaging way, potentially leading to better outcomes.12346
Research Team
Murat Akcakaya, PhD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for adults over 18 who've had a stroke and are in inpatient rehab. They must have trouble noticing things on one side (neglect), be able to hear well, respond to vibrations, speak English, and miss targets in an AR test. People with dementia, Parkinson's disease, MS, brain tumors or metal implants that affect EEGs can't join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the Augmented Reality (AR)-based and electroencephalography (EEG)-based neglect detection and rehabilitation tool
Follow-up
Participants are monitored for satisfaction and effectiveness of the AR and EEG-based tool
Treatment Details
Interventions
- Augmented Reality (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
David Apelian
University of Pittsburgh
Chief Executive Officer since 2019
PhD in Molecular Biology from Rutgers University, MD from the University of Medicine and Dentistry of New Jersey, MBA from Quinnipiac University
Pamela D. Garzone
University of Pittsburgh
Chief Medical Officer
PhD in Clinical Science from the University of Pittsburgh
Northeastern University
Collaborator
Jared Auclair
Northeastern University
Chief Executive Officer
PhD in Biomedical Science from the University of Massachusetts Medical School
Anantdeep Kaur
Northeastern University
Chief Medical Officer since 2023
Master’s and Doctorate in Biotechnology from the University of Technology Sydney
NSF
Collaborator